ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2518

Does the Cytokine Pattern, Including the IL23 – IL17 Immune Axis, Change in Pregnant Women with Psoriatic Arthritis?

Andrea Pluma-Sanjurjo1, Peter M. Villiger2 and Frauke Förger3, 1Rheumatology, University Hospital Vall d'Hebron, Barcelona, Spain, 2Professor & Head, Bern, Switzerland, 3Rheumatology, Clinical Immunology and Allergology, Inselspital-University Hospital, Bern, Switzerland

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: cytokines, pregnancy and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Reproductive Issues in Rheumatic Disorders: Basic and Clinical Aspects Poster Session

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

During pregnancy, most patients with Psoriatic Arthritis (PsA) experience a natural improvement of their symptoms. This might be due to the immunological changes that occur in normal pregnancy to allow tolerance to the semiallogeneic fetus. Pregnancy induces a down-regulation of the adaptative immune system and generates a specific cytokine milieu. The balance between T helpers cells (Th), Th1/Th2/Th17, depends on the cytokine milieu and interleukin (IL) 23 promotes the expansion and survival of Th17 cells. The IL23-IL17 axis is up-regulated in PsA. 

Objective:

The aim of our study is to investigate changes of the cytokines pattern with focus on the IL23-IL17 immune axis during and after pregnancy in PsA patients compared with non-pregnant PsA patients and healthy controls (HC).

Methods:

Nineteen PsA patients (10 pregnant, 9 non-pregnant) and 19 HC (11 pregnant and 8 non-pregnant) were prospectively studied. Clinical assessment and blood sampling was done in pregnant women before, during and after pregnancy and once in the non-pregnant group. Sera were analyzed for levels of C reactive protein (CRP) and high sensitive CRP (hsCRP) by enzyme linked immunoassay. The following cytokines and regulatory molecules were measured by magnetic bead-based multiplex immunoassay: the activation marker soluble CD40 ligand (sCD40L), the Th1 cytokines tumor necrosis factor α (TNFα) and Interleukin (IL)-1β, the Th2 cytokines IL-4, IL-10, IL-31, IL-33, IL-25 and the Th 23/17 pathway cytokines IL-6, IL-17A, IL-17F, IL-21, IL-22, IL23.

Results:

In the non-pregnant groups we observed that patients with PsA had higher levels of hsCRP, sCD40L, TNFα, IL-1β, IL-33, IL-6 and IL-22 than HC.

Though pregnant PsA patients had inactive or mild disease activity with normal CRP levels, the hsCRP levels were higher than those of pregnant HC.

In the HC group, pregnant women at the third trimester showed higher levels of IL-10, IL-33 and TNFα than at the postpartum time point. Moreover, healthy women at the third trimester had higher levels of IL-1β, IL-33 and IL-22 than age-matched non-pregnant women.

At the third trimester of pregnancy, patients with PsA displayed higher levels of hsCRP, sCD40L, TNFα and IL-6 than HC. Interestingly, pregnant PsA patients did not show any differences in the cytokine pattern compared to non-pregnant PsA patients.

Most differences appeared when comparing PsA and HC at the postpartum time point. Postpartal patients with PsA showed higher levels of sCD40L, TNFα, IL-1β,IL-10, IL-33, IL-31, IL-6 and IL-22 compared to HC. 

Conclusion:

Pregnancy induces no predominance of circulating Th2 cytokines but rather a coexistence of Th1, Th2 and Th17 cytokines. Patients with PsA present a more pronounced inflammatory profile consisting of elevated hsCRP levels, Th1 and Th17 cytokines during pregnancy and postpartum. Thus, inactive disease in pregnant PsA patients was associated with persisting immunological activity including the IL-23 /Th17 immune axis.


Disclosure: A. Pluma-Sanjurjo, None; P. M. Villiger, None; F. Förger, None.

To cite this abstract in AMA style:

Pluma-Sanjurjo A, Villiger PM, Förger F. Does the Cytokine Pattern, Including the IL23 – IL17 Immune Axis, Change in Pregnant Women with Psoriatic Arthritis? [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/does-the-cytokine-pattern-including-the-il23-il17-immune-axis-change-in-pregnant-women-with-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/does-the-cytokine-pattern-including-the-il23-il17-immune-axis-change-in-pregnant-women-with-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology